Canbisol
Canbisol is a synthetic cannabinoid that was developed in the 1970s. It is a non-psychoactive compound, meaning it does not produce the "high" associated with cannabis. Canbisol has been studied for its potential therapeutic uses, particularly in the treatment of glaucoma and epilepsy.
History
Canbisol was first synthesized in the 1970s by a team of researchers at the University of Mississippi. The team was led by Dr. Raphael Mechoulam, a renowned chemist known for his work on cannabinoids. The goal of the research was to create a synthetic cannabinoid that could be used for medical purposes without the psychoactive effects of cannabis.
Structure and Properties
Canbisol is a synthetic cannabinoid, meaning it is not naturally occurring but is chemically similar to the cannabinoids found in the cannabis plant. It is a non-psychoactive compound, which means it does not produce the "high" associated with cannabis use. This makes it a potential candidate for therapeutic uses where the psychoactive effects of cannabis are not desired.
Medical Uses
Canbisol has been studied for its potential therapeutic uses. It has been found to be particularly effective in the treatment of glaucoma, a condition that causes increased pressure in the eye and can lead to vision loss. Canbisol works by reducing intraocular pressure, helping to prevent damage to the optic nerve.
In addition to its use in treating glaucoma, Canbisol has also been studied for its potential use in treating epilepsy. Some studies have found that it can reduce the frequency and severity of seizures in some patients.
Legal Status
The legal status of Canbisol varies by country. In some countries, it is classified as a controlled substance, while in others it is legal for medical use. It is important to check the laws in your specific location before using Canbisol.
See Also
Canbisol
Structure of Canbisol
3D Ball-and-Stick Model of Canbisol
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
